Joseph and Wolf Lebovic Cancer Genomics and Immunity Fellowship Program
Eligibility:
Eligibility
- OICR is making funding available to investigators based in, or formally affiliated with, an Ontario Host Institution such as a university, research institute, research hospital, or not-for-profit organization with an explicit research mandate;
- Proposals are to be submitted jointly by two PIs, one from each institute. A Digital Form has been created to facilitate the identification of potential collaborators;
- PIs may submit only one proposal per funding cycle; and
- PIs that were awarded a fellowship in the first round of the program are eligible to submit a proposal for the second round, however, the fellow cannot be the same
How to Apply:
The Joseph and Wolf Lebovic Cancer Genomics and Immunity Fellowship Program aims to support projects that will uncover the diverse interactions between tumour and immune cells, for the development of new therapeutic strategies. The program aims to harness the power of genomic analytic tools with that of diverse animal and cellular experimental systems, through collaborative work between the Ontario Institute for Cancer Research (OICR) and the Institute for Medical Research Israel-Canada (IMRIC) scientists. IMRIC an institute of the Hebrew University.
Scope
- The program will provide support for trainees – students/postdoctoral fellows – working on joint projects between IMRIC and Ontario-based scientists addressing the interactions between cancer and immune cells;
- Two projects will be selected to receive support over a two-year period;
- Each collaborative project will support two trainees, one from each institution; and
- Each project will be funded at $80,000 CAD per year divided equally between the two institutions ($40,000 CAD per institution per year).
External Deadline:
Tuesday, July 30, 2019
Funding Source:
External
Funding Level:
Doctoral
Masters
Research